Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.

Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R. · 2020

Read Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. by Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7164518.txt.

Description

Zhang and co-authors determine the crystal structure of the SARS-CoV-2 main protease and improve a drug that blocks it, in Science. The protease cuts long viral polyproteins into working pieces, making it one of the best-characterised drug targets among coronaviruses. Without it, the virus cannot assemble its machinery.

They solved the enzyme's structure by X-ray crystallography and refined an alpha-ketoamide inhibitor into a potent lead compound. Structures of the inhibitor bound to the protease, at 1.95 and 2.20 angstrom resolution, show exactly how it grips the active site. The work lays a concrete basis for developing anticoronavirus drugs aimed at this enzyme.

Catalog record

CREATORZhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7164518

Browse the full library · About the Tower of Babel